Cargando…

mTOR pathway – a potential therapeutic target in stroke

Stroke is ranked as the second leading cause of death worldwide and a major cause of long-term disability. A potential therapeutic target that could offer favorable outcomes in stroke is the mammalian target of rapamycin (mTOR) pathway. mTOR is a serine/threonine kinase that composes two protein com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melanis, Konstantinos, Stefanou, Maria-Ioanna, Themistoklis, Konstantinos M., Papasilekas, Themistoklis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413897/ https://www.ncbi.nlm.nih.gov/pubmed/37576547 http://dx.doi.org/10.1177/17562864231187770

Ejemplares similares

Hemorrhagic complications after removal of an external ventricular drain: A case report and literature review
por: Plakopitis, Nikolaos, et al.
Publicado: (2023)

mTOR Signaling and Potential Therapeutic Targeting in Meningioma
por: Pinker, Benjamin, et al.
Publicado: (2022)

mTOR: A Potential Therapeutic Target in Osteoarthritis?
por: Pal, Bandna, et al.
Publicado: (2015)

mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases
por: Wang, Yipin, et al.
Publicado: (2022)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Anterior Cervical Discectomy and Fusion combined with thyroid gland surgery, a tailored case and literature review
por: Themistoklis, Konstantinos M., et al.
Publicado: (2019)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

The role of mTOR pathway as target for treatment in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
por: Popova, Nadezhda V., et al.
Publicado: (2021)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
por: Zhang, Fen, et al.
Publicado: (2023)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

mTOR Pathways in Cancer and Autophagy
por: Paquette, Mathieu, et al.
Publicado: (2018)

The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022)

mTOR pathway in colorectal cancer: an update
por: Francipane, Maria Giovanna, et al.
Publicado: (2013)

The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials
por: Malley, Cian O., et al.
Publicado: (2015)

The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration
por: Heras-Sandoval, David, et al.
Publicado: (2011)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022)

NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
por: Indini, Alice, et al.
Publicado: (2022)

Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019)

Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
por: Katsimichas, Themistoklis, et al.
Publicado: (2023)

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
por: Evangelisti, Camilla, et al.
Publicado: (2018)

Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
por: Karagianni, Fani, et al.
Publicado: (2022)

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma
por: Folgiero, Valentina, et al.
Publicado: (2016)

mTOR pathway: A current, up-to-date mini-review (Review)
por: ZAROGOULIDIS, PAUL, et al.
Publicado: (2014)

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
por: AlQurashi, Naif, et al.
Publicado: (2013)

mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
por: Ayuk, Sandra M., et al.
Publicado: (2019)

mTOR signalling pathway in stem cell bioactivities and angiogenesis potential
por: Lotfimehr, Hamid, et al.
Publicado: (2023)

The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012)

mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma
por: Michishita, Masaki, et al.
Publicado: (2023)

Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
por: Singh, Shilpi, et al.
Publicado: (2023)

mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
por: Babicheva, Aleksandra, et al.
Publicado: (2021)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

Targeting the mTOR pathway in Chromophobe Kidney Cancer
por: Shuch, Brian, et al.
Publicado: (2012)

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014)

Targeting mTOR pathway: A new concept in cancer therapy
por: Advani, S. H.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0kqqe2g5e8260sps5tr8qlqc64